AU2001272961A1 - Compositions for treating bacterial infections containing oxazolidinone compound, sulbactam and an ampicillin - Google Patents
Compositions for treating bacterial infections containing oxazolidinone compound, sulbactam and an ampicillinInfo
- Publication number
- AU2001272961A1 AU2001272961A1 AU2001272961A AU7296101A AU2001272961A1 AU 2001272961 A1 AU2001272961 A1 AU 2001272961A1 AU 2001272961 A AU2001272961 A AU 2001272961A AU 7296101 A AU7296101 A AU 7296101A AU 2001272961 A1 AU2001272961 A1 AU 2001272961A1
- Authority
- AU
- Australia
- Prior art keywords
- sulbactam
- ampicillin
- compositions
- bacterial infections
- treating bacterial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21541800P | 2000-06-30 | 2000-06-30 | |
US60/215,418 | 2000-06-30 | ||
US23277300P | 2000-09-15 | 2000-09-15 | |
US60/232,773 | 2000-09-15 | ||
US27930601P | 2001-03-28 | 2001-03-28 | |
US60/279,306 | 2001-03-28 | ||
PCT/US2001/019712 WO2002002095A2 (en) | 2000-06-30 | 2001-06-21 | Compositions for treating bacterial infections containing oxazolidinone compound, sulbactam and an ampicillin |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001272961A1 true AU2001272961A1 (en) | 2002-01-14 |
Family
ID=27396119
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001272961A Abandoned AU2001272961A1 (en) | 2000-06-30 | 2001-06-21 | Compositions for treating bacterial infections containing oxazolidinone compound, sulbactam and an ampicillin |
Country Status (14)
Country | Link |
---|---|
US (1) | US6544991B2 (en) |
EP (1) | EP1301207B1 (en) |
JP (1) | JP2004501965A (en) |
AR (1) | AR029544A1 (en) |
AT (1) | ATE301474T1 (en) |
AU (1) | AU2001272961A1 (en) |
DE (1) | DE60112581T2 (en) |
DK (1) | DK1301207T3 (en) |
ES (1) | ES2245698T3 (en) |
MY (1) | MY128739A (en) |
PE (1) | PE20020295A1 (en) |
PT (1) | PT1301207E (en) |
TW (1) | TWI265030B (en) |
WO (1) | WO2002002095A2 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030096850A1 (en) * | 2001-10-11 | 2003-05-22 | Ford Charles W. | Treating infections by administration of oxazolidinones |
IL164195A0 (en) * | 2002-03-29 | 2005-12-18 | Upjohn Co | Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections |
WO2003093247A2 (en) * | 2002-04-30 | 2003-11-13 | Orchid Chemicals & Pharmaceuticals Ltd | Antibacterial agents |
BRPI0611070A2 (en) * | 2005-05-06 | 2010-08-03 | Wyeth Corp | composition; pharmaceutical composition; combination therapy; medical apparatus; method for administering at least one glycylcycline and at least one heparin; method for the administration of glycylcycline and heparin; method of treating intraabdominal infections with complications (ciai) and cutaneous infections and complications of the cutaneous structure (csssi) caused by gram negative and gram positive pathogens, anaerobic and methicillin-resistant strains and those resistant to staphylococcus aureus ( mssa and mrsa); method of treating intraabdominal infections with complications (ciai) and infections of the cutaneous and complicating skin structure (csssi) caused by gram negative and gram positive pathogens, anaerobic and methicillin-resistant strains of staphylococcus aureus ( mssa and mrsa) in a patient in need; antibiotic administration method; article of manufacture; kit; use of a glycylcillin of formula I or a pharmaceutically acceptable salt thereof; use of a heparin or pharmaceutically acceptable salt thereof; and product |
ES2335307T3 (en) | 2005-06-29 | 2010-03-24 | PHARMACIA & UPJOHN COMPANY LLC | HOMOMORFOLIN OXALIDINONAS AS ANTIBACTERIAL AGENTS. |
WO2007086013A1 (en) * | 2006-01-25 | 2007-08-02 | Jegannathan Srinivas | Formulation comprising of ceftazidime, tazobactam and linezolid |
WO2007086014A1 (en) * | 2006-01-25 | 2007-08-02 | Jegannathan Srinivas | Formulation comprising cefpirome, tazobactam and linezolid |
WO2007086012A1 (en) * | 2006-01-25 | 2007-08-02 | Jegannathan Srinivas | Formulation of cefpodoxime, clavulanic acid and linezolid |
WO2007086011A1 (en) * | 2006-01-25 | 2007-08-02 | Jegannathan Srinivas | Formulation comprising cefepime, tazobactam and linezolid |
WO2008090570A1 (en) * | 2007-01-25 | 2008-07-31 | Panacea Biotec Ltd | Novel antimicrobials |
EP2367820B1 (en) | 2008-11-20 | 2016-09-21 | Panacea Biotec Limited | Novel antimicrobial agents |
US8906913B2 (en) | 2009-06-26 | 2014-12-09 | Panacea Biotec Limited | Azabicyclohexanes |
WO2017066964A1 (en) | 2015-10-22 | 2017-04-27 | Merck Sharp & Dohme Corp. | Oxazolidinone compounds and methods of use thereof as antibacterial agents |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2985648A (en) | 1958-10-06 | 1961-05-23 | Doyle Frank Peter | Alpha-aminobenzylpenicillins |
GB902703A (en) | 1960-08-25 | 1962-08-09 | Beecham Res Lab | Penicillins |
BE641785A (en) | 1962-12-26 | |||
US4234579A (en) | 1977-06-07 | 1980-11-18 | Pfizer Inc. | Penicillanic acid 1,1-dioxides as β-lactamase inhibitors |
SK283420B6 (en) | 1992-05-08 | 2003-07-01 | Pharmacia & Upjohn Company | Oxazolidinones containing a substituted diazine moiety and their use as antimicrobials |
US5688792A (en) | 1994-08-16 | 1997-11-18 | Pharmacia & Upjohn Company | Substituted oxazine and thiazine oxazolidinone antimicrobials |
DE4425613A1 (en) | 1994-07-20 | 1996-01-25 | Bayer Ag | 5-membered heteroaryl oxazolidinones |
DE4425612A1 (en) | 1994-07-20 | 1996-04-04 | Bayer Ag | 6-membered nitrogen-containing heteroaryl oxazolidinones |
DE19514313A1 (en) | 1994-08-03 | 1996-02-08 | Bayer Ag | Benzoxazolyl- and Benzothiazolyloxazolidinone |
NZ315469A (en) | 1995-09-01 | 2000-01-28 | Upjohn Co | Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings |
DE19601265A1 (en) | 1996-01-16 | 1997-07-17 | Bayer Ag | 2-oxo and 2-thio-1,2-dihydroquinolinyl oxazolidinones |
DE19601264A1 (en) | 1996-01-16 | 1997-07-17 | Bayer Ag | Pyrido-annellated thienyl and furanyl oxazolidinones |
DE19601627A1 (en) | 1996-01-18 | 1997-07-24 | Bayer Ag | Cyclopentanopyridyl oxazolidinones containing heteroatoms |
US5684024A (en) | 1996-01-25 | 1997-11-04 | Viropharma Incorporated | Pyrazole dimers compositions and methods for treating influenza |
DE19604223A1 (en) | 1996-02-06 | 1997-08-07 | Bayer Ag | New substituted oxazolidinones |
GB9702213D0 (en) | 1996-02-24 | 1997-03-26 | Zeneca Ltd | Chemical compounds |
ES2166073T3 (en) | 1996-04-11 | 2002-04-01 | Upjohn Co | PROCEDURE TO PREPARE OXAZOLIDINONES. |
KR100619639B1 (en) | 1997-11-07 | 2006-09-06 | 파마시아 앤드 업존 캄파니 엘엘씨 | Process to Produce Oxazolidinones |
NZ513292A (en) | 1999-02-01 | 2003-08-29 | Upjohn Co | Process to prepare cyclic-sulfur fluorine containing oxazolidinones |
-
2001
- 2001-06-21 DK DK01952176T patent/DK1301207T3/en active
- 2001-06-21 US US09/886,641 patent/US6544991B2/en not_active Expired - Fee Related
- 2001-06-21 WO PCT/US2001/019712 patent/WO2002002095A2/en active IP Right Grant
- 2001-06-21 AT AT01952176T patent/ATE301474T1/en not_active IP Right Cessation
- 2001-06-21 ES ES01952176T patent/ES2245698T3/en not_active Expired - Lifetime
- 2001-06-21 PT PT01952176T patent/PT1301207E/en unknown
- 2001-06-21 DE DE60112581T patent/DE60112581T2/en not_active Expired - Fee Related
- 2001-06-21 JP JP2002506717A patent/JP2004501965A/en active Pending
- 2001-06-21 EP EP01952176A patent/EP1301207B1/en not_active Expired - Lifetime
- 2001-06-21 AU AU2001272961A patent/AU2001272961A1/en not_active Abandoned
- 2001-06-28 PE PE2001000643A patent/PE20020295A1/en not_active Application Discontinuation
- 2001-06-29 MY MYPI20013131A patent/MY128739A/en unknown
- 2001-06-29 TW TW090115958A patent/TWI265030B/en not_active IP Right Cessation
- 2001-06-29 AR ARP010103125A patent/AR029544A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1301207B1 (en) | 2005-08-10 |
US6544991B2 (en) | 2003-04-08 |
JP2004501965A (en) | 2004-01-22 |
DE60112581T2 (en) | 2006-06-01 |
ATE301474T1 (en) | 2005-08-15 |
MY128739A (en) | 2007-02-28 |
WO2002002095B1 (en) | 2004-03-25 |
DK1301207T3 (en) | 2005-10-10 |
AR029544A1 (en) | 2003-07-02 |
WO2002002095A3 (en) | 2003-02-06 |
DE60112581D1 (en) | 2005-09-15 |
US20020022610A1 (en) | 2002-02-21 |
PT1301207E (en) | 2005-11-30 |
TWI265030B (en) | 2006-11-01 |
ES2245698T3 (en) | 2006-01-16 |
WO2002002095A2 (en) | 2002-01-10 |
EP1301207A2 (en) | 2003-04-16 |
PE20020295A1 (en) | 2002-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001268564A1 (en) | Alpha-glycosylceramides for treating bacterial and fungal infections | |
MXPA03003168A (en) | Topical antibiotic composition for treatment of eye infection. | |
SI1427711T1 (en) | Oxazolidinone and/or isoxazoline derivatives as antibacterial agents | |
GB0125222D0 (en) | Composition for the treatment of microbial infections | |
WO2003088897A3 (en) | Fab i inhibitors | |
AU2001272961A1 (en) | Compositions for treating bacterial infections containing oxazolidinone compound, sulbactam and an ampicillin | |
ZA200108215B (en) | Compositions and methods for treatment of staphylococcal infection. | |
AU2002232558A1 (en) | Compounds, compositions and methods for treatment of parasitic infections | |
AU2003299561A1 (en) | Compositions and methods for treating bacterial infections with protein-dalbavancin complexes | |
AU2002258054A1 (en) | Oxazolidinone derivatives as antimicrobials | |
AU2001257490A1 (en) | Improved beta-lactam antibiotics | |
AU2002333278A1 (en) | Solid composition containing Bacillus-type non-pathogenic bacterial spores | |
AU2002256995A1 (en) | Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods | |
AU2002220378A1 (en) | Regulation of bacterial virulence | |
AU5029700A (en) | Glycopeptide antibacterial compounds, compositions containing same and methods of using same | |
AU2001275085A1 (en) | Methods, compounds and compositions for treating gout | |
AU2247701A (en) | Gram-positive selective antibacterial compounds, compositions containing such compounds and methods of treatment | |
AU2003210258A1 (en) | Piperidine ouracil used as a medicament for treating bacterial infections | |
AU2003239132A1 (en) | Methods and compositions for preventing and treating microbial infections | |
AU1212501A (en) | Gram-positive selective antibacterial compounds, compositions containing such compounds and methods of treatment | |
AU2002353774A1 (en) | Products and methods for treating microbial infections | |
AU2003261782A1 (en) | Bacteriophages and remedies for bacterial infection | |
AU2003292420A1 (en) | Antibacterial oxazolidinones | |
AU1646701A (en) | Composition for treating respiratory tract infections | |
MXPA03001531A (en) | Solution composition of an oxazolidinone antibiotic drug having enhanced drug loading. |